These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 24135743)
1. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. Thaivalappil S; Bauman N; Saieg A; Movius E; Brown KJ; Preciado D JAMA Otolaryngol Head Neck Surg; 2013 Oct; 139(10):1026-31. PubMed ID: 24135743 [TBL] [Abstract][Full Text] [Related]
2. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. Bauman NM; McCarter RJ; Guzzetta PC; Shin JJ; Oh AK; Preciado DA; He J; Greene EA; Puttgen KB JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):323-30. PubMed ID: 24526257 [TBL] [Abstract][Full Text] [Related]
3. [Effects of oral propranolol on urine bFGF, MMP-2, MMP-9 expression in children with proliferative infantile hemangioma]. Yuan WL; Wang XK Shanghai Kou Qiang Yi Xue; 2022 Aug; 31(4):400-405. PubMed ID: 36710554 [TBL] [Abstract][Full Text] [Related]
4. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes. Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699 [TBL] [Abstract][Full Text] [Related]
5. Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study. Malik MA; Menon P; Rao KL; Samujh R J Pediatr Surg; 2013 Dec; 48(12):2453-9. PubMed ID: 24314186 [TBL] [Abstract][Full Text] [Related]
6. Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy. Kleber CJ; Spiess A; Kleber JB; Hinz U; Holland-Cunz S; Weiss J Eur J Pediatr; 2012 Jun; 171(6):941-6. PubMed ID: 22203431 [TBL] [Abstract][Full Text] [Related]
7. Tissue and serum mRNA profile of MMPs-2/9 as a potential novel biomarker for the most individual approach in infantile hemangiomas and cancer disease. Taran K; Wnęk A; Kobos J; Andrzejewska E; Przewratil P Immunobiology; 2017 Nov; 222(11):1035-1042. PubMed ID: 28601470 [TBL] [Abstract][Full Text] [Related]
11. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial. Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828 [TBL] [Abstract][Full Text] [Related]
14. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid. López-Gutiérrez JC Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264 [TBL] [Abstract][Full Text] [Related]
15. Treatment for Infantile Hemangiomas: Selection Criteria, Safety, and Outcomes Using Oral Propranolol During the Early Phase of Propranolol Use for Hemangiomas. MacIsaac ZM; Nayar HS; Gehris R; Mehta D; Geisler S; Grunwaldt LJ J Craniofac Surg; 2016 Jan; 27(1):159-62. PubMed ID: 26674892 [TBL] [Abstract][Full Text] [Related]
16. Propranolol and infantile hemangiomas four years later: a systematic review. Marqueling AL; Oza V; Frieden IJ; Puttgen KB Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852 [TBL] [Abstract][Full Text] [Related]
17. [Propranolol in infantile hemangiomas]. Léauté-Labrèze C Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275 [TBL] [Abstract][Full Text] [Related]